SERPINI2
Serpin I2
Also known as: MEPI, PI14, SPI2_HUMAN, TSA2004
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75830
- Gene
- SERPINI2
- Ensembl
- ENSG00000114204
- Chromosome
- 3
- Canonical length
- 405 aa
- Protein class
- Predicted secreted proteins
- Secretome location
- Secreted to digestive system
OverviewNCBI Gene
The gene encodes a member of a family of proteins that acts as inhibitors of serine proteases. These proteins function in the regulation of a variety of physiological processes, including coagulation, fibrinolysis, development, malignancy, and inflammation. Expression of the encoded protein may be downregulated during pancreatic carcinogenesis. Alternative splicing results in multiple transcript variants for this gene. [provided by RefSeq, Jan 2013]
Canonical amino-acid sequenceUniProt
405 residues, UniProt reviewed canonical sequence.
>O75830|SERPINI2
1 MDTIFLWSLL LLFFGSQASR CSAQKNTEFA VDLYQEVSLS HKDNIIFSPL GITLVLEMVQ
61 LGAKGKAQQQ IRQTLKQQET SAGEEFFVLK SFFSAISEKK QEFTFNLANA LYLQEGFTVK
121 EQYLHGNKEF FQSAIKLVDF QDAKACAEMI STWVERKTDG KIKDMFSGEE FGPLTRLVLV
181 NAIYFKGDWK QKFRKEDTQL INFTKKNGST VKIPMMKALL RTKYGYFSES SLNYQVLELS
241 YKGDEFSLII ILPAEGMDIE EVEKLITAQQ ILKWLSEMQE EEVEISLPRF KVEQKVDFKD
301 VLYSLNITEI FSGGCDLSGI TDSSEVYVSQ VTQKVFFEIN EDGSEAATST GIHIPVIMSL
361 AQSQFIANHP FLFIMKHNPT ESILFMGRVT NPDTQEIKGR DLDSLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SERPINI2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 1,339 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 1,339 nTPM
- fallopian tube: 5 nTPM
- choroid plexus: 2.7 nTPM
- small intestine: 2.3 nTPM
- basal ganglia: 1.9 nTPM
- lung: 1.2 nTPM
Single-cell type
- pancreatic acinar cells: 623 nCPM
- ependymal cells: 621 nCPM
- respiratory ciliated cells: 461 nCPM
- bergmann glia: 337 nCPM
- choroid plexus epithelial cells: 244 nCPM
- astrocytes: 153 nCPM
Immune cell
- plasmacytoid DC: 0.5 nTPM
- classical monocyte: 0.1 nTPM
- myeloid DC: 0.1 nTPM
- basophil: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- medulla oblongata: 26 nTPM
- choroid plexus: 25 nTPM
- spinal cord: 24 nTPM
- midbrain: 20 nTPM
- white matter: 15 nTPM
- cerebellum: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SERPINI2.
Disease | ImmuneIEDB
Conditions an epitope on SERPINI2 was assayed in.
- hepatocellular carcinoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.53
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.45
- DepMap mean gene effect
- 0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SERPINI2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SERPINI2 as an antibody target. Whether an autoantibody or antibody against SERPINI2 could matter depends on whether native SERPINI2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SERPINI2 is annotated as secreted, so native SERPINI2 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label SERPINI2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...